在万古霉素筛选的金黄色葡萄球菌分离株中，对自溶的抗性先于万古霉素中介抗性出现。
Resistance to autolysis in vancomycin-selected Staphylococcus aureus isolates precedes vancomycin-intermediate resistance.
作者信息
Boyle-Vavra Susan, Challapalli Mamatha, Daum Robert S
机构信息
Department of Pediatrics, The University of Chicago, Chicago, Illinois 60637, USA.
出版信息
Antimicrob Agents Chemother. 2003 Jun;47(6):2036-9. doi: 10.1128/AAC.47.6.2036-2039.2003.
Abstract
Four clinical U.S. glycopeptide intermediate resistant Staphylococcus aureus (GISA) isolates were resistant to Triton X-100-induced autolysis. Similar resistance was demonstrated in an isolate obtained after a single passage of a susceptible clinical isolate in low-level vancomycin. Strains with the vancomycin-induced Triton X-100 resistance phenotype produced active murein hydrolases but were resistant to lysis by murein hydrolases.
摘要
美国的4株临床糖肽类中介耐药金黄色葡萄球菌（GISA）分离株对Triton X-100诱导的自溶具有抗性。在一株敏感临床分离株在低水平万古霉素中传代一次后获得的分离株中也表现出类似的抗性。具有万古霉素诱导的Triton X-100抗性表型的菌株产生活性胞壁质水解酶，但对胞壁质水解酶的裂解具有抗性。
相似文献
1
Resistance to autolysis in vancomycin-selected Staphylococcus aureus isolates precedes vancomycin-intermediate resistance.
Antimicrob Agents Chemother. 2003 Jun;47(6):2036-9. doi: 10.1128/AAC.47.6.2036-2039.2003.
2
Antimicrobial Activity of Galangin and Its Effects on Murein Hydrolases of Vancomycin-Intermediate Staphylococcus aureus (VISA) Strain Mu50.
Chemotherapy. 2018;63(1):20-28. doi: 10.1159/000481658. Epub 2017 Nov 17.
3
Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin.
Antimicrob Agents Chemother. 2002 May;46(5):1492-502. doi: 10.1128/AAC.46.5.1492-1502.2002.
4
Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains.
J Antimicrob Chemother. 2005 Nov;56(5):944-7. doi: 10.1093/jac/dki289. Epub 2005 Sep 12.
5
Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate.
J Antimicrob Chemother. 2001 Nov;48(5):617-25. doi: 10.1093/jac/48.5.617.
6
Role of the Operon in Cell Wall Biosynthesis, Autolysis, Integrity, and Antibiotic Resistance in Staphylococcus aureus.
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00680-19. Print 2019 Oct.
7
Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
Clin Infect Dis. 2009 Oct 15;49(8):1169-74. doi: 10.1086/605636.
8
Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function.
Antimicrob Agents Chemother. 2005 Jul;49(7):2687-92. doi: 10.1128/AAC.49.7.2687-2692.2005.
9
Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals.
J Clin Microbiol. 1999 Nov;37(11):3590-3. doi: 10.1128/JCM.37.11.3590-3593.1999.
10
Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates.
J Infect Dis. 2002 Sep 1;186(5):661-7. doi: 10.1086/342708. Epub 2002 Aug 1.
引用本文的文献
1
Update on bacterial pathogens: virulence and resistance.
Enferm Infecc Microbiol Clin. 2008 Apr;26:3-21. doi: 10.1016/S0213-005X(08)76378-X. Epub 2009 May 13.
2
Genetic characterization of tetracycline-resistant Staphylococcus aureus with reduced vancomycin susceptibility using whole-genome sequencing.
Arch Microbiol. 2023 Dec 16;206(1):24. doi: 10.1007/s00203-023-03760-0.
3
Adaptive Laboratory Evolution of Resistance to Vancomycin and Daptomycin: Mutation Patterns and Cross-Resistance.
Antibiotics (Basel). 2023 May 18;12(5):928. doi: 10.3390/antibiotics12050928.
4
New Antimicrobial Resistance Strategies: An Adaptive Resistance Network Conferring Reduced Glycopeptide Susceptibility in VISA.
Antibiotics (Basel). 2023 Apr 19;12(4):783. doi: 10.3390/antibiotics12040783.
5
The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus.
Microbiol Spectr. 2021 Oct 31;9(2):e0052821. doi: 10.1128/Spectrum.00528-21. Epub 2021 Oct 20.
6
VraCP regulates cell wall metabolism and antibiotic resistance in vancomycin-intermediate Staphylococcus aureus strain Mu50.
J Antimicrob Chemother. 2021 Jun 18;76(7):1712-1723. doi: 10.1093/jac/dkab113.
7
Antimicrobial Resistance in ESKAPE Pathogens.
Clin Microbiol Rev. 2020 May 13;33(3). doi: 10.1128/CMR.00181-19. Print 2020 Jun 17.
8
Long-term methicillin-resistant Staphylococcus aureus bacteremia persisting for more than 2 weeks: risk factors and outcomes.
Eur J Clin Microbiol Infect Dis. 2020 Apr;39(4):773-781. doi: 10.1007/s10096-019-03795-6. Epub 2019 Dec 23.
9
Antibiotic release from F-doped nanotubular oxide layer on TI6AL4V alloy to decrease bacterial viability.
J Mater Sci Mater Med. 2018 Jul 20;29(8):118. doi: 10.1007/s10856-018-6119-4.
10
Vancomycin Resistance in
.
Yale J Biol Med. 2017 Jun 23;90(2):269-281. eCollection 2017 Jun.
本文引用的文献
1
Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate.
J Antimicrob Chemother. 2001 Nov;48(5):617-25. doi: 10.1093/jac/48.5.617.
2
Whole genome sequencing of meticillin-resistant Staphylococcus aureus.
Lancet. 2001 Apr 21;357(9264):1225-40. doi: 10.1016/s0140-6736(00)04403-2.
3
Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999.
MMWR Morb Mortal Wkly Rep. 2000 Jan 7;48(51-52):1165-7.
4
Analysis of genetic elements controlling Staphylococcus aureus lrgAB expression: potential role of DNA topology in SarA regulation.
J Bacteriol. 2000 Sep;182(17):4822-8. doi: 10.1128/JB.182.17.4822-4828.2000.
5
A new two-component regulatory system involved in adhesion, autolysis, and extracellular proteolytic activity of Staphylococcus aureus.
J Bacteriol. 2000 Jul;182(14):3955-64. doi: 10.1128/JB.182.14.3955-3964.2000.
6
The Staphylococcus aureus lrgAB operon modulates murein hydrolase activity and penicillin tolerance.
J Bacteriol. 2000 Apr;182(7):1794-801. doi: 10.1128/JB.182.7.1794-1801.2000.
7
Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds.
Antimicrob Agents Chemother. 2000 Feb;44(2):294-303. doi: 10.1128/AAC.44.2.294-303.2000.
8
Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia.
Emerg Infect Dis. 1999 Jan-Feb;5(1):147-9. doi: 10.3201/eid0501.990118.
9
The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.
N Engl J Med. 1999 Feb 18;340(7):517-23. doi: 10.1056/NEJM199902183400704.
10
Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.
J Antimicrob Chemother. 1998 Aug;42(2):199-209. doi: 10.1093/jac/42.2.199.
Zotero 插件